Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

14.50
Delayed Data
As of Jul 21
 +0.65 / +4.69%
Today’s Change
8.51
Today|||52-Week Range
17.20
+19.34%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close13.85
Today’s open14.00
Day’s range13.85 - 14.50
Volume347,661
Average volume (3 months)671,560
Market cap$705.8M
Dividend yield--
Data as of 07/21/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-728.21%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratio181.3
Price/Sales4.86
Price/Book6.25

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-1.24-1.22%
ENTAEnanta Pharmaceutica...+1.05+2.88%
RETAReata Pharmaceutical...+0.66+2.17%
RVNCRevance Therapeutics...+0.95+4.17%
Data as of 07/21/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts